Latest Articles
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers - BW Healthcare World
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers BW Healthcare World
Published: Aug. 26, 2025, 8:55 a.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - India Education Diary
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers India Education Diary
Published: Aug. 25, 2025, 3:28 p.m.
GSK forays into oncology in India bringing precision therapies for gynaecological cancers - BioSpectrum India
GSK forays into oncology in India bringing precision therapies for gynaecological cancers BioSpectrum India
Published: Aug. 25, 2025, 2:19 p.m.
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers - APN News
GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers APN News
Published: Aug. 25, 2025, 11:04 a.m.
GSK enters into oncology segment; launches therapies for gynaecological cancers - newsdrum.in
GSK enters into oncology segment; launches therapies for gynaecological cancers newsdrum.in
Published: Aug. 25, 2025, 8 a.m.
Incidental Primary Ovarian Squamous Cell Carcinoma Arising in Endometriosis Presenting As Adenomyosis-Related Abnormal Uterine Bleeding.
Adenomyosis often coexists with endometriosis, which primarily involves the ovary and can lead to endometriosis‑associated ovarian cancers, most commonly endometrioid and clear‑cell carcinomas. Ovarian squamous cell carcinoma (OSCC) arising in …
Published: Aug. 22, 2025, midnight
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers - TipRanks
Sutro Biopharma’s STRO-002: A Promising Phase 1 Trial Update in Ovarian and Endometrial Cancers TipRanks
Published: Aug. 20, 2025, 4:06 p.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers - APN News
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers APN News
Published: Aug. 7, 2025, 5:45 a.m.
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post
Published: Aug. 6, 2025, 3:38 p.m.
Uterine Cancers Outpace Clinical Tools to Curb Them - Medscape
Uterine Cancers Outpace Clinical Tools to Curb Them Medscape
Published: Aug. 5, 2025, 12:02 p.m.
Link copied to clipboard!